FDA Inspection 1332548 — Erasmus University Medical Center
The FDA completed an inspection of Erasmus University Medical Center on Jul 24, 2026 in Rotterdam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rotterdam (Netherlands)
Additional Details
Sponsor, Contract Research Organization